Literature DB >> 19405324

Iliopsoas abscess: a re-emerging clinical entity not to be forgotten.

Z Al-Hilli, R S Prichard, G Roche-Nagle, J Deasy, D A McNamara.   

Abstract

Iliopsoas abscesses are relatively rare clinical entities. They present with subtle and non-specific symptoms and as a result the diagnosis is often delayed, leading to significant morbidity and mortality. With an increasing number of immunocompromised patients in the population the prevalence of this condition is set to rise. Therefore, early diagnosis and appropriate management remain a challenge for clinicians. We present three patients with iliopsoas abscesses, two of which were primary and one of which was secondary to Crohn's disease. The average age of patients was 59 years and both patients with primary psoas abscesses were male. All presented with non-specific symptoms. Psoas sign was present in only one patient. CT confirmed the diagnosis in all cases. Treatment consisted of appropriate antibiotic cover and associated percutaneous drainage. The psoas abscess that was secondary to underlying Crohn's disease was subsequently treated with surgical excision of the affected segment of bowel and lavage of the abscess cavity. A high index of suspicion is required to ensure the accurate and early diagnosis of this rare clinical entity. Abdominal CT scanning remains the gold standard for diagnosis. Management is with appropriate antibiotics and adequate drainage. This can be achieved by either percutaneous or surgical drainage. Such treatment can reduce the overall morbidity and mortality of this condition.

Entities:  

Mesh:

Year:  2009        PMID: 19405324

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  2 in total

1.  Photoletter to the editor: Oral ulceration in pyoderma gangrenosum.

Authors:  Saroj Verma; Sinead Field; Gillian Murphy
Journal:  J Dermatol Case Rep       Date:  2011-06-06

2.  Primary extrahepatic alveolar echinococcosis of the lumbar spine and the psoas muscle.

Authors:  Manuel Nell; Rainer H Burgkart; Guntmar Gradl; Rüdiger von Eisenhart-Rothe; Christoph Schaeffeler; Dennis Trappe; Clarissa Prazeres da Costa; Reiner Gradinger; Chlodwig Kirchhoff
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-04-15       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.